David Kilian Selected Research

N- (alpha- ethylbenzyl)- 3- (carboxymethoxy)- 2- phenylquinoline- 4- carboxamide

1/2002

Nonpeptide tachykinin receptor antagonists. III. SB 235375, a low central nervous system-penetrant, potent and selective neurokinin-3 receptor antagonist, inhibits citric acid-induced cough and airways hyper-reactivity in guinea pigs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David Kilian Research Topics

Disease

1	Hypoxia (Hypoxemia) 06/2022
1	Infertility (Sterility) 01/2019
1	Neoplasms (Cancer) 01/2018
1	Cough 01/2002
1	Miosis 01/2002

Drug/Important Bio-Agent (IBA)

1	Proteins (Proteins, Gene)FDA Link 06/2022
1	OsteocalcinIBA 06/2022
1	Biocompatible Materials (Biomaterials)IBA 01/2019
1	Citric Acid (Citrate)FDA LinkGeneric 01/2002
1	N- (alpha- ethylbenzyl)- 3- (carboxymethoxy)- 2- phenylquinoline- 4- carboxamideIBA 01/2002
1	Neurokinin-3 ReceptorsIBA 01/2002
1	senktideIBA 01/2002

Therapy/Procedure

1	Immunotherapy 01/2018
1	Therapeutics 01/2018